US 10562884
Melanocortin subtype-2 receptor (MC2R) antagonists and uses thereof
granted A61PA61P5/00
Quick answer
US patent 10562884 (Melanocortin subtype-2 receptor (MC2R) antagonists and uses thereof) held by CRINETICS PHARMACEUTICALS, INC. expires Mon Feb 13 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- CRINETICS PHARMACEUTICALS, INC.
- Grant date
- Tue Feb 18 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 13 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61P, A61P5/00